These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15694189)

  • 1. Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma.
    Morris EC; Mackinnon S
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):129-42. PubMed ID: 15694189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma.
    Sureda A
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease.
    Hale GA; Phillips GL
    Cancer Treat Rev; 2000 Dec; 26(6):411-27. PubMed ID: 11139372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic transplantation in lymphoma: current status.
    Schmitz N; Dreger P; Glass B; Sureda A
    Haematologica; 2007 Nov; 92(11):1533-48. PubMed ID: 18024402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
    Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
    Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion.
    Todisco E; Castagna L; Sarina B; Mazza R; Anastasia A; Balzarotti M; Banna G; Tirelli U; Soligo D; Santoro A
    Eur J Haematol; 2007 Apr; 78(4):322-9. PubMed ID: 17253967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma.
    Tomblyn M; Winter JN
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):281-94. PubMed ID: 12820773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional allograft and autograft in low grade lymphoma.
    Avivi I; Goldstone AH
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?
    Ho AY; Pagliuca A
    Hematology; 2002 Dec; 7(6):345-54. PubMed ID: 12475739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous stem cell transplantation in lymphomas and Hodgkin's disease].
    Greinix HT
    Acta Med Austriaca Suppl; 2000; 52():25-9. PubMed ID: 11261274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic cell transplantation in non-Hodgkin's lymphoma.
    Steingass SK
    Semin Oncol Nurs; 2006 May; 22(2):107-16. PubMed ID: 16720233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
    Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
    Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation for pediatric lymphoma: past, present and future.
    Bradley MB; Cairo MS
    Bone Marrow Transplant; 2008 Jan; 41(2):149-58. PubMed ID: 18084337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation for non-Hodgkin lymphoma.
    Nademanee A
    Expert Rev Hematol; 2009 Aug; 2(4):425-42. PubMed ID: 21082947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A; Forman SJ
    Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.